None of the 11 cases evaluated by whole-exome sequencing carried large CTNNB1 deletions or mutations in exons 7 or 8, the latter described in a minority of bHCA and previously shown to activate β-catenin in HCC cell lines [18]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.